Genetic testing for monogenic forms of motor neuron disease/amyotrophic lateral sclerosis in unaffected family members
Open Access
- 5 November 2024
- journal article
- review article
- Published by Springer Nature in European Journal of Human Genetics
- Vol. 33 (1) , 7-13
Abstract
Motor neuron disease (MND), also referred to as amyotrophic lateral sclerosis (ALS), is a monogenic disease in a minority of cases, with autosomal dominant inheritance. Increasing numbers of people with MND are requesting genetic testing, and indeed receiving a genetic diagnosis. Consequently, requests for genetic counselling and predictive testing (i.e. of unaffected family members) are similarly expected to rise, alongside pre-symptomatic clinical trials. Despite this, there is no evidence-based guideline for predictive genetic testing in MND. This paper provides an overview of the genomic basis of MND, focusing specifically on the most common monogenic causes of MND. It then lays out the complexities of MND predictive testing, including the genetic landscape characterised by incomplete penetrance, clinical and genetic heterogeneity, and an oligogenic mechanism of pathogenesis in some cases. Additionally, there is limited research on the psychosocial impact of predictive genetic testing for MND, with studies suggesting potential difficulty in adjusting to the news, in part due to a lack of support and follow-up. This underscores a case for evidence-based, disease-specific guidance for predictive testing in MND.Keywords
This publication has 60 references indexed in Scilit:
- Experiences of predictive genetic testing in inherited motor neuron disease: Findings from a qualitative interview studyJournal of Genetic Counseling, 2024
- Evidence‐based consensus guidelines for ALS genetic testing and counselingAnnals of Clinical and Translational Neurology, 2023
- The lived experience of reconstructing identity in response to genetic risk of frontotemporal degeneration and amyotrophic lateral sclerosisJournal of Genetic Counseling, 2023
- Genetic counseling and diagnostic genetic testing for familial amyotrophic lateral sclerosis and/or frontotemporal dementia: A qualitative study of client experiencesJournal of Genetic Counseling, 2022
- Amyotrophic lateral sclerosis is over-represented in two Huntington’s disease brain bank cohorts: further evidence to support genetic pleiotropy of pathogenic HTT gene expansionActa Neuropathologica, 2021
- Oligogenicity, C9orf72 expansion, and variant severity in ALSneurogenetics, 2020
- Use of Genetic Testing in Amyotrophic Lateral Sclerosis by NeurologistsJAMA Neurology, 2017
- Patients with Amyotrophic Lateral Sclerosis Have High Interest in and Limited Access to Genetic TestingJournal of Genetic Counseling, 2016
- Analysis of the Reasons for Non‐Uptake of Predictive Testing for Huntington's Disease in Spain: A Qualitative StudyJournal of Genetic Counseling, 2015
- The Psychological Impact of Predictive Genetic Testing for Huntington′s Disease: A Systematic Review of the LiteratureJournal of Genetic Counseling, 2014